Fri.Jan 12, 2018

Spark CEO Marrazzo on Gene Therapy Pricing & Paving the Way for the Field

Xconomy

After decades of research and scientific ups and downs, the first U.S. gene therapy, a single, long-lasting treatment called voretigene neparvovec (Luxturna) for rare, inherited blindness, is now on the market. But the commercial challenge facing its developer, Spark Therapeutics, is daunting. Can Spark lead the way in showing that the new kinds of payment models it is experimenting with will succeed in getting the healthcare system to pay for such pricey, one-time treatments?

Silicon Beach Report Jan. 12: Snapchat’s Big Redesign Rated Negatively by 83% of Reviews

L.A. Business Journal

Snapchat’s big redesign rated negatively by 83 percent of reviews; Pentagon refuses to answer questions about failed $1 billion Zuma satellite launch; and The IMDb Show launched

Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More

Xconomy

Have you gotten your flu shot yet this year? This winter’s flu season is shaping up to be a particularly nasty one and the Centers for Disease Control and Prevention this week upped its tally of states reporting widespread flu activity to 46. Flu awareness was top of mind at the J.P. Morgan Healthcare Conference held this week in rainy San Francisco.

Southern California Edison Plans New EV Transportation Pilots

socalTECH

Southern California Edison said late Thursday afternoon that it has received approval to launch four new, electric vehicle transportation pilots, which will help expand the adoption of electric vehicles. According to Edison,the four pilot projects--worth around $4M each--were approved by the California Public Utilities Commission, and are part of a much larger effort to expand the electrification of cars, buses, medium- and heavy-duty trucks, and industrial vehicles and equipment.

More Trending

Acorns Gets Investment From TPG

socalTECH

Irvine-based micro-investing app developer Acorns said this morning that it has received an investment from private equity investor TPG, via TPG's The Rise Fund, which is focused on companies in the social and environmental area. According to Acorns, the investment by TPG's Rise Fund is the first in a fintech company. Size of the investment was not announced by the company.